High-grade B-cell lymphoma with 11q aberrations: A single-center study
Journal of Clinical and Experimental Hematopathology · 2023 · 63 (2) · 121-131
DOI: 10.3960/jslrt.23007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical and Experimental Hematopathology, 2023. Verfasst von Shoki Yamada und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic Pathology, Fukushima Medical University School of Medicine, Fukushima, Japan. Hauptthemen laut MEDLINE: Chromosome Aberrations, Burkitt Lymphoma. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Diagnostic Pathology, Fukushima Medical University School of Medicine, Fukushima, Japan.
Zitieren
APA
Yamada, S., Oka, Y., Muramatsu, M., & Hashimoto, Y. (2023). High-grade B-cell lymphoma with 11q aberrations: A single-center study. Journal of Clinical and Experimental Hematopathology, 63(2), 121-131. https://doi.org/10.3960/jslrt.23007
Vancouver
Yamada S, Oka Y, Muramatsu M, Hashimoto Y. High-grade B-cell lymphoma with 11q aberrations: A single-center study. Journal of Clinical and Experimental Hematopathology. 2023;63(2):121-131. doi:10.3960/jslrt.23007
BibTeX
@article{Yamada2023,
author = {Yamada, Shoki and Oka, Yuka and Muramatsu, Moe and Hashimoto, Yuko},
title = {High-grade B-cell lymphoma with 11q aberrations: A single-center study},
journal = {Journal of Clinical and Experimental Hematopathology},
year = {2023},
volume = {63},
number = {2},
pages = {121--131},
doi = {10.3960/jslrt.23007}
}
EUVIMED